Browsing: company

Target for self-developed AI advancement Recruitment of a multi-agency expert evaluation team From the 17th to the 28th, Newgium Lab, a clinical nutrition AI company, will introduce the concept and development direction of the clinical nutrition vertical AI “NUSEUM AI” currently being developed on the first floor of Korea University Guro Hospital’s Future Hall. [NU’EST…

On August 10, Eli Lilly and Company (NYSE:LLY)’s weight-loss pill Foundayo won approval in the UK, becoming the first country in Europe to clear the drug for both weight management and type 2 diabetes. It’s only the second GLP-1 pill approved in Europe, arriving two months after Novo Nordisk A/S (NYSE:NVO)’s Wegovy pill got its…

The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE:NVO) filed a lawsuit in U.S. District Court in New Jersey against Eli Lilly and Company (NYSE:LLY) on July 21, accusing its primary rival of false advertising and unfair competition regarding television and digital campaigns…

Popular San Francisco-based telehealth company Hims & Hers is being sued by federal regulators and California, who allege the company enrolled consumers in recurring prescription subscriptions without proper consent and shared sensitive health information with advertising platforms, including Meta and Snap, despite promising to protect users’ privacy